Laurent-Perrier S.A. (EPA:LPE)

Verve Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	547	586	713	703	567	470
Market Cap Growth	-17.83%	-17.83%	1.48%	23.86%	20.74%	5.83%
Enterprise Value	767	826	917	909	844	795
Last Close Price	93.40	96.42	115.78	112.53	88.76	72.86
PE Ratio	11.68	12.36	11.22	12.02	11.29	18.61
Forward PE	11.09	10.51	12.40	12.77	14.87	25.48
PS Ratio	1.86	1.99	2.28	2.28	1.86	2.41
PB Ratio	0.87	0.93	1.19	1.28	1.13	1.03
P/TBV Ratio	0.92	0.98	1.26	1.36	1.21	1.11
P/FCF Ratio	-	-	-	12.41	8.26	137.41
P/OCF Ratio	1955.00	2093.03	61.16	10.83	7.50	59.19
PEG Ratio	1.31	1.95	1.95	1.95	1.95	1.95
EV/Sales Ratio	2.61	2.81	2.93	2.95	2.76	4.08
EV/EBITDA Ratio	9.38	10.27	9.14	10.01	10.29	17.03
EV/EBIT Ratio	10.32	11.12	9.68	10.66	11.04	19.30
EV/FCF Ratio	-58.65	-	-	16.04	12.29	232.56
Debt / Equity Ratio	0.43	0.43	0.40	0.52	0.69	0.83
Debt / EBITDA Ratio	3.34	3.34	2.36	3.09	4.19	7.85
Debt / FCF Ratio	-	-	-	5.01	5.08	109.69
Asset Turnover	0.28	0.28	0.31	0.31	0.31	0.21
Inventory Turnover	0.19	0.19	0.20	0.23	0.27	0.17
Quick Ratio	0.80	0.80	0.57	1.19	1.77	1.49
Current Ratio	5.36	5.36	4.16	6.14	7.23	8.19
Return on Equity (ROE)	7.75%	7.75%	11.15%	11.22%	10.54%	5.68%
Return on Assets (ROA)	4.44%	4.44%	5.89%	5.35%	4.89%	2.70%
Return on Capital (ROIC)	5.33%	5.33%	7.07%	6.33%	5.68%	3.15%
Return on Capital Employed (ROCE)	8.00%	8.00%	11.40%	9.70%	8.60%	4.70%
Earnings Yield	8.66%	8.09%	8.91%	8.32%	8.85%	5.37%
FCF Yield	-2.39%	-2.23%	-0.25%	8.06%	12.10%	0.73%
Dividend Yield	2.25%	2.18%	1.81%	1.78%	1.35%	1.37%
Payout Ratio	26.22%	26.22%	18.66%	20.21%	11.78%	24.12%
Buyback Yield / Dilution	0.17%	0.17%	-0.42%	0.39%	-0.02%	0.02%
Total Shareholder Return	2.38%	2.35%	1.40%	2.17%	1.34%	1.40%

Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.